FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100363034> ?p ?o ?g. }

• W3100363034 endingPage "2273" @default.
• W3100363034 startingPage "2256" @default.
• W3100363034 abstract "Aims Hypophosphataemia is an increasingly recognized side-effect of ferric carboxymaltose (FCM) and possibly iron isomaltoside/ferric derisomaltose (IIM), which are used to treat iron deficiency. The aim of this study was to determine frequency, severity, duration and risk factors of incident hypophosphataemia after treatment with FCM and IIM. Methods A systematic literature search for articles indexed in EMBASE, PubMed and Web of Science in years 2005-2020 was carried out using the search terms 'ferric carboxymaltose' OR 'iron isomaltoside'. Prospective clinical trials reporting outcomes on hypophosphataemia rate, mean nadir serum phosphate and/or change in mean serum phosphate from baseline were selected. Hypophosphataemia rate and severity were compared for studies on IIM vs. FCM after stratification for chronic kidney disease. Meta-regression analysis was used to investigate risk factors for hypophosphataemia. Results Across the 42 clinical trials included in the meta-analysis, FCM induced a significantly higher incidence of hypophosphataemia than IIM (47%, 95% CI 36-58% vs. 4%, 95% CI 2-5%), and significantly greater mean decreases in serum phosphate (0.40 vs. 0.06 mmol/L). Hypophosphataemia persisted at the end of the study periods (maximum 3 months) in up to 45% of patients treated with FCM. Meta-regression analysis identified low baseline serum ferritin and transferrin saturation, and normal kidney function as significant predictors of hypophosphataemia. Conclusion FCM is associated with a high risk of hypophosphataemia, which does not resolve for at least 3 months in a large proportion of affected patients. More severe iron deficiency and normal kidney function are risk factors for hypophosphataemia." @default.
• W3100363034 created "2020-11-23" @default.
• W3100363034 creator A5008906136 @default.
• W3100363034 creator A5042597905 @default.
• W3100363034 creator A5047522708 @default.
• W3100363034 creator A5048743509 @default.
• W3100363034 creator A5050626665 @default.
• W3100363034 creator A5088680222 @default.
• W3100363034 creator A5091593739 @default.
• W3100363034 date "2020-12-07" @default.
• W3100363034 modified "2023-10-16" @default.
• W3100363034 title "Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside—a systematic review and meta‐analysis" @default.
• W3100363034 cites W1498732084 @default.
• W3100363034 cites W1549105976 @default.
• W3100363034 cites W1723550313 @default.
• W3100363034 cites W1981476022 @default.
• W3100363034 cites W1993527690 @default.
• W3100363034 cites W2000112317 @default.
• W3100363034 cites W2020869593 @default.
• W3100363034 cites W2021092349 @default.
• W3100363034 cites W2021355963 @default.
• W3100363034 cites W2022858531 @default.
• W3100363034 cites W2026902073 @default.
• W3100363034 cites W2033623500 @default.
• W3100363034 cites W2034350751 @default.
• W3100363034 cites W2049193031 @default.
• W3100363034 cites W2065640977 @default.
• W3100363034 cites W2073934849 @default.
• W3100363034 cites W2090172304 @default.
• W3100363034 cites W2097503522 @default.
• W3100363034 cites W2103992480 @default.
• W3100363034 cites W2107213267 @default.
• W3100363034 cites W2114568194 @default.
• W3100363034 cites W2116642832 @default.
• W3100363034 cites W2117734216 @default.
• W3100363034 cites W2125206681 @default.
• W3100363034 cites W2126702786 @default.
• W3100363034 cites W2128540381 @default.
• W3100363034 cites W2139168999 @default.
• W3100363034 cites W2147606462 @default.
• W3100363034 cites W2148904142 @default.
• W3100363034 cites W2148904824 @default.
• W3100363034 cites W2150702340 @default.
• W3100363034 cites W2159151833 @default.
• W3100363034 cites W2169161951 @default.
• W3100363034 cites W2205873021 @default.
• W3100363034 cites W2292259692 @default.
• W3100363034 cites W2296467055 @default.
• W3100363034 cites W2416733161 @default.
• W3100363034 cites W2466673568 @default.
• W3100363034 cites W2531573155 @default.
• W3100363034 cites W2556729497 @default.
• W3100363034 cites W2557622425 @default.
• W3100363034 cites W2588548713 @default.
• W3100363034 cites W2604745390 @default.
• W3100363034 cites W2605985957 @default.
• W3100363034 cites W2749138180 @default.
• W3100363034 cites W2785721765 @default.
• W3100363034 cites W2794233777 @default.
• W3100363034 cites W2800826661 @default.
• W3100363034 cites W2802104057 @default.
• W3100363034 cites W2884235408 @default.
• W3100363034 cites W2891406159 @default.
• W3100363034 cites W2892108047 @default.
• W3100363034 cites W2902343043 @default.
• W3100363034 cites W2903270600 @default.
• W3100363034 cites W2922821435 @default.
• W3100363034 cites W2953771124 @default.
• W3100363034 cites W2955819440 @default.
• W3100363034 cites W2973198758 @default.
• W3100363034 cites W2999543897 @default.
• W3100363034 cites W2999781826 @default.
• W3100363034 cites W3004562070 @default.
• W3100363034 cites W3005591251 @default.
• W3100363034 cites W3026203946 @default.
• W3100363034 cites W4235279993 @default.
• W3100363034 doi "https://doi.org/10.1111/bcp.14643" @default.
• W3100363034 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8247006" @default.
• W3100363034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33188534" @default.
• W3100363034 hasPublicationYear "2020" @default.
• W3100363034 type Work @default.
• W3100363034 sameAs 3100363034 @default.
• W3100363034 citedByCount "44" @default.
• W3100363034 countsByYear W31003630342020 @default.
• W3100363034 countsByYear W31003630342021 @default.
• W3100363034 countsByYear W31003630342022 @default.
• W3100363034 countsByYear W31003630342023 @default.
• W3100363034 crossrefType "journal-article" @default.
• W3100363034 hasAuthorship W3100363034A5008906136 @default.
• W3100363034 hasAuthorship W3100363034A5042597905 @default.
• W3100363034 hasAuthorship W3100363034A5047522708 @default.
• W3100363034 hasAuthorship W3100363034A5048743509 @default.
• W3100363034 hasAuthorship W3100363034A5050626665 @default.
• W3100363034 hasAuthorship W3100363034A5088680222 @default.
• W3100363034 hasAuthorship W3100363034A5091593739 @default.
• W3100363034 hasBestOaLocation W31003630341 @default.
• W3100363034 hasConcept C126322002 @default.
• W3100363034 hasConcept C2777417653 @default.

• next